The treatment of choice for hyperthyroidism in pregnancy is antithyroid drugs, but the potential risk of birth defects is of major concern. For the use of thiamazole and carbimazole, there is consistent evidence of an increased risk of birth defects, which are often severe. For the use of propylthiouracil, the evidence is less clear. These birth defects may be less severe, and a Danish study which included all birth defects diagnosed before the age of two years showed an increased risk of birth defects in the face and neck region and in the urinary system after the use of propylthouracil.</p
Objective The aim of this study was to determine the effect of exposure to different antithyroid d...
Aims: Maternal antithyroid drug (ATD) use during pregnancy has been associated with an increased ris...
Context: Graves’ disease affects 3% of women and 0.5% of men in the general population. The first li...
Clinical hyperthyroidism has been associated with an increased risk of maternal, fetal, and neonatal...
BACKGROUND: Rare cases of birth defects after the use of methimazole (MMI) or carbimazole to treat h...
Aims Maternal antithyroid drug (ATD) use during pregnancy has been associated with an increased ris...
Introduction: Hyperthyroidism in pregnant women should be adequately treated to prevent maternal and...
BACKGROUND: Antithyroid drugs (ATDs) may have teratogenic effects when used in early pregnancy.OBJEC...
Context: Clinical hyperthyroidism is not uncommon in pregnancy, with a reported prevalence of 0.1 to...
Thyroid hormones are essential development factors and maternal thyroid dysfunction may cause pregna...
To evaluate the association of either propylthiouracil or methimazole treatment for hyperthyroidism ...
To evaluate the association of either propylthiouracil or methimazole treatment for hyperthyroidism ...
Objective To compare, using two large nationwide population-based data sets, the risk of adverse pre...
The aim of this study was to determine the effect of exposure to different antithyroid drugs during ...
Background: Propylthiouracil (PTU) used in the treatment of maternal hyperthyroidism in early pregna...
Objective The aim of this study was to determine the effect of exposure to different antithyroid d...
Aims: Maternal antithyroid drug (ATD) use during pregnancy has been associated with an increased ris...
Context: Graves’ disease affects 3% of women and 0.5% of men in the general population. The first li...
Clinical hyperthyroidism has been associated with an increased risk of maternal, fetal, and neonatal...
BACKGROUND: Rare cases of birth defects after the use of methimazole (MMI) or carbimazole to treat h...
Aims Maternal antithyroid drug (ATD) use during pregnancy has been associated with an increased ris...
Introduction: Hyperthyroidism in pregnant women should be adequately treated to prevent maternal and...
BACKGROUND: Antithyroid drugs (ATDs) may have teratogenic effects when used in early pregnancy.OBJEC...
Context: Clinical hyperthyroidism is not uncommon in pregnancy, with a reported prevalence of 0.1 to...
Thyroid hormones are essential development factors and maternal thyroid dysfunction may cause pregna...
To evaluate the association of either propylthiouracil or methimazole treatment for hyperthyroidism ...
To evaluate the association of either propylthiouracil or methimazole treatment for hyperthyroidism ...
Objective To compare, using two large nationwide population-based data sets, the risk of adverse pre...
The aim of this study was to determine the effect of exposure to different antithyroid drugs during ...
Background: Propylthiouracil (PTU) used in the treatment of maternal hyperthyroidism in early pregna...
Objective The aim of this study was to determine the effect of exposure to different antithyroid d...
Aims: Maternal antithyroid drug (ATD) use during pregnancy has been associated with an increased ris...
Context: Graves’ disease affects 3% of women and 0.5% of men in the general population. The first li...